JUBLIA (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the JUBLIA drug offered from Valeant Pharmaceuticals North America LLC. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: efinaconazole
SUBSTANCE NAME: EFINACONAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Azole Antifungal [EPC],Azoles [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-06-06
END MARKETING DATE: 0000-00-00


JUBLIA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionJUBLIA from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2014-06-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-5400_424ea0a1-aaad-43b3-b0be-f78c27e8858c
PRODUCT NDC: 0187-5400
APPLICATION NUMBER: NDA203567

Other EFINACONAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Valeant Pharmaceuticals North America LLCJUBLIA